Cepheid (company)

Cepheid
	Cepheid headquarters in Sunnyvale
Company type	Subsidiary
Industry	Biotechnology; Medical devices;
Founded	March 1996
Headquarters	Sunnyvale, California, U.S.
Key people	John L. Bishop; (Chairman & CEO); Warren Kocmond; (President & COO); Dr. David Persing; (Chief Medical Officer);
Revenue	US$531.08 million (August 2016)
Number of employees	2,000 (2021)
Parent	Danaher Corporation
Website	cepheid.com
	Footnotes / references;

Cepheid is an American molecular diagnostics company that is a wholly owned subsidiary of Danaher Corporation. Its systems automate traditional nucleic acid tests (tests for specific sequences of DNA or RNA). The tests can be used to identify and analyze pathogens and genetic disorders. Cepheid sells clinical tests for healthcare-associated infections, infectious diseases, sexual health, oncology and genetics.

The cartridges used in Cepheid's testing machines are single-use and must be bought from the manufacturer. The company has been accused of profiteering, particularly in developing countries, by pricing the cartridges at many times the cost of production, and engaging in price discrimination.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.